Call for Abstracts

Congress Format
The JES 2026 Annual Meeting is scheduled to be held as an in-person event.
All presentations will be conducted in person, and no live streaming is planned.
However, on-demand streaming will be available for selected sessions.
Abstract Submission Guidelines
  • ●Abstracts will be accepted through online registration using the UMIN system.
  • ●The name of the presenting author and the abstract title must be entered in both Japanese and English if submitted in Japanese.
  • ●Although the presentation can be in Japanese, the abstract text can be written in either Japanese or English (English abstracts are recommended).
  • ●General abstracts (Oral presentations: English) are also being widely solicited. We welcome submissions for presentations in English. Participants studying in Japan will have their registration fees waived.
  • ●In general, the first author is the presenter.
  • ●For sessions with international speakers, please register an English abstract.
  • ●The registration number and password issued at the time of abstract submission are required for confirmation of receipt and for making corrections, so please be sure to keep a record of them.
  • ●Please read the important notes carefully, and then proceed to the abstract submission page by clicking the button at the bottom of this page.
  • ●Supported Browsers: Firefox, Google Chrome, Microsoft Edge and Safari.
Abstract Submission Categories

Oral presentations in Japanese,

Oral presentations in English,

Poster presentations
Open Call

Invited Abstracts

(excluding General Presentation

and Symposium)

By Invitation Only

Note: Only those specifically invited can submit. Submissions

from others will be invalid.
Abstract Submission Period

General Abstracts & Symposium:

From Tuesday, March 24, at noon – Friday, May 8, 2026, at 17:00 (JST)
Presentation Format
General presentation, Symposiums, Workshops
For general presentation, symposiums, and workshops, please select your preferred presentation format (oral presentation, poster, symposium/workshop) during the registration process.
However, please note that we may not be able to accommodate all preferences.
The acceptance and presentation format decisions will be made by the program committee. After abstract review, notifications regarding acceptance, presentation format, abstract number, etc., will be sent via email (expected to be in mid July 2026).
Invited Topics
Please select the requested session.
If you require any special accommodation on the day of the presentation (e.g., wheelchair access), please indicate this on the registration page and inform the secretariat.
Ethical Standards (Important)
It is a requirement for submission that the research does not involve any ethical issues. The presenter will bear ethical responsibility when presenting. When registering the abstract, please comply with the "Ethical Considerations for Abstract Submission at the Annual Meeting" established by the Japan Epilepsy Society and answer the questions on the abstract registration page accordingly.
For more details, please refer to the following link.
https://jes-jp.org/jes/pdf/JES_nextyaer_rinrirule.pdf
Awards
1. Best Poster Award
Overview
 Outstanding abstracts from the general poster presentations will be selected for each category (Psychiatry, Neurology, Pediatrics, Neurosurgery, Basic Research, and Co-medical).
Eligibility
 The first author must be under 40 years old as of April 1, 2026.
Application
 Self-declaration and application are required at the time of abstract submission.
2. English Presentation Award
Overview
 Outstanding presentations delivered in English will be awarded.
Eligibility
 There is no age restriction, and no prior application is required.*After the abstract submission has closed, we will contact those who selected “1.
Oral Presentation (Japanese/English)” to confirm their interest in being considered for the award.
3. YES-Japan Excellent Presentation Award (YES-Japan Award)
Overview
 Outstanding abstracts from general poster presentations will be recognized.
Eligibility
 The first author must be under 40 years old and belong to one of the following categories:
- Medical students
- Junior residents
- Senior residents/Clinical fellows
- Medical staff
4. YES-Japan English Session Excellent Presentation Award
(YES-Japan English Session Award)
Overview
 Outstanding abstracts from both oral and poster presentations will be recognized.
Eligibility
 The first author must be under 40 years old and belong to one of the following categories:
- Medical students
- Junior residents
- Senior residents/Clinical fellows
- Medical staff
Additional Information
The abstract for the YES-Japan English session can be the same as the general abstract. However, an English abstract must be submitted in Word format to the conference office at jes59@shinsen-mc.co.jp.
5. Awards (1, 2, 3 Common)
Award Ceremony
The awards are scheduled to be presented at the closing ceremony of the Annual Meeting.
Eligibility and Conditions
The first author of the general abstract is considered the presenter. Furthermore, the first author must be a regular or temporary member of the Japan Epilepsy Society.
Non-members must contact the society office and complete the membership process (either regular or temporary) at the time of abstract submission.
If a temporary member is the first author, at least one of the co-authors must be a regular member.
Membership Procedure
The Japan Epilepsy Society Office
URL：http://square.umin.ac.jp/jes/gaiyo/entrance-guide.html
E-mail：jes-oas@umin.ac.jp
TEL・FAX：+81-42-345-2522
Cautions for Inputting Registration Details
Session Selection
You need to choose between the following options for your presentation type:
Select Your Presentation Type
Oral Presentation, Poster Presentation, Symposium/Workshop
1
 Oral Presentation:
Choose this option if you will be presenting orally, either in Japanese or English.
2
 Poster Presentation:
If you prefer a poster presentation, select this option, again with either Japanese or English.
3
 Symposium/Workshop:
If you’re presenting as part of a symposium or workshop, select this option and indicate your preferred language for the oral presentation (Japanese or English).
Specified Topics
1
 Educational Lecture
2
 Special Lecture
3
 Committee-Planned Lecture
4
 Others
Maximum Number of Authors Allowed for Registration
First author + co-authors: 15 people
Maximum Number of Affiliated Institutions Allowed for Registration
15 institutions
Category Selection
Category Selection 1 (General Presentations)
Please select the categories from the following list, indicating your 1st and 2nd choices for presentation format (Oral or Poster):
01
 Etiology/Epidemiology
02
 Underlying Condition/Disease
03
 Classification/Syndrome
04
 Genetics
05
 Ictal Semiology
06
 EEG/MEG/Neurophysiology
07
 Neuroimaging
08
 Medication
09
 Surgery
10
 Other Treatment
11
 Clinical Course/Prognosis
12
 Social Aspect/QOL
13
 Comorbidity
14
 Psychiatric Symptom
15
 Development/Neuropsychology
16
 Comprehensive/Integrated Care
17
 Medical System
18
 Medical Staff Session
19
 Adverse Effect
20
 Pharmacology
21
 Physiology
22
 Pathology
23
 Biochemistry
24
 Neurotransmitter
25
 Experimental Epilepsy
26
 Case Report
27
 Art, History
28
 Translational research
Abstract Words Count
For General Presentation, Symposium and Workshop
(for both Japanese and English Oral and Poster Presentations)
Title
- Full width (Japanese): up to 50 characters
- Half width (English): up to 25 words
Abstract (body text)
- Full width (Japanese): up to 800 characters
- Half width (English): up to 220 words
Total Words Count including (Author, affiliation, title and abstract text)
- Full width (Japanese): up to 1,100 characters
- Half width (English): up to 300 words
Excluding General Presentation, Symposium and Workshop
(for designated presentations)
Title
- Full width (Japanese): up to 50 characters
- Half width (English): up to 25 words
Abstract (body text)
- Full width (Japanese): up to 1,200 characters
- Full width (English): up to 350 words
Total Words Count including (Author, affiliation, title and abstract text)
- Full width (Japanese) up to 1,500 characters
- Half width (English) up to 430 words
The abstract body text should be divided into the following sections
- Objective
- Method
- Results
- Conclusion
Duplicate Presentations
Abstracts with the same content as those presented at past Annual Meetings of Japan Epilepsy Society.
If the content overlaps with that submitted to another past meeting, please send the abstracts submitted to the other meeting to the 59th JES Annual Meeting Secretariat（e-mail：jes59@shinsen-mc.co.jp）.
If the presentation content has received any awards from other meeting or publication in the past, please indicate this award history when submitting your application.
Please note that when submitting abstract records for various specialist certification applications, duplicate presentations will be considered as a single presentation.
Therefore, presenters are responsible for avoiding duplicate submissions when applying for these certifications.
Disclosure of Conflicts of Interest (COI)
  • ●In order to appropriately promote clinical research through industry-academia collaboration and to ensure the scientific and ethical integrity of the research results, all presenters are required to disclose any conflicts of interest (COI) to ensure neutrality and transparency in the presentation of clinical research findings.
  • ●Please answer the "Conflict of Interest (COI)" questions in the system at the time of abstract submission.
  • ●For the detailed information on the Policy on Conflicts of Interest (COI) in Clinical Research, click here.
  • ●Please contact the Secretariat of the Japan Epilepsy Society (see below) for any technical questions on COI.
COI Disclosure Form (Template)
for Oral and Poster Presentations at the annual meeting.

Form 2: Disclosure of COI
Secretariat of the Japan Epilepsy Society
https://square.umin.ac.jp/jes/
4-6-15 Ogawahigashi-cho, Kodaira City, Tokyo, 187-0031, Japan
E-mail：jes-oas@umin.ac.jp
TEL and FAX：+81-42-345-2522
Abstract Submission

New Submission ≫

Login to Confirm, Modify, or Withdraw ≫

Page
Top